Pero vaz de caminha: An interchange for quality control between Brazil and Portugal

Acta Cytologica

Volumn 50, Issue 3, 2006, Pages 303-308

  Utagawa, Maria Lúcia ^a   Di Loreto, Celso ^a   De Freitas, Cristina ^b   Milanezi, Fernanda ^b,c   Longatto Filho, Adhemar ^a,c   Pereira, Sónia Maria Miranda ^a   Maeda, Marina Yoshiê Sakamoto ^a   Schmitt, Fernando C ^b,d  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d University of Porto   (Portugal)

Author keywords

Cervical cancer; Health care quality assurance; Mass screening; Papanicolaou smear; Quality control

Indexed keywords

ARTICLE; BRAZIL; CANCER GRADING; CANCER SCREENING; CONTINUING EDUCATION; CYTOPATHOLOGY; FEMALE; HEALTH CARE QUALITY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MASS SCREENING; PAPANICOLAOU TEST; PORTUGAL; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; QUALITY CONTROL; RELIABILITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

PERO;

EID: 33744823780     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325958     Document Type: Article

References (41)

1. Mody DR, Davey DD, Branca M, Raab SS, Schenck UG, Stanley MW, Wright RG, Arbyn M, Beccati D, Bishop JW, Collaço LM, Cramer S, Fitzgerald P, Heirich J, Jhala NC, Montanari G, Kapila K, Narychk, Suprun HZ: Quality assurance and risk reduction guidelines. Acta Cytol 2000;44:496-507
2. Franco EF, Duarte-Franco E, Ferenczy A: Prospects for controlling cervical cancer at the turn of the century. Salud Publica Mex 2003;45:S367-S375
3. Marrett LD, Robles S, Ashbury FD, Green B, Goel V, Luciani S: A proposal for cervical screening information systems in developing countries. Int J Cancer 2002;102:293-299
4. Hanselaar AG: Criteria for organized cervical screening programs: Special emphasis on the Netherlands program. Acta Cytol 2002;46:619-629
5. Van der Graaf Y, Vooijs GP: False negative rate in cervical cytology. J Clin Pathol 1987;40:438-442
6. Vooijs GP, Elias A, Van der Graaf Y, Veling S: Relantionship between the diagnoses of epithelial abnormalities and the composition of cervical smears. Acta Cytol 1985;29:323-328
7. Vooijs GP: Replies to questions on quality assurance measures in cytopathology. Acta Cytol 1988;32:936-939
8. Eisenberger D, Hernandez E, Tener T, Alkinson BF: Order of endocervical and ectocervical cytologic sampling and the quality of the Papanicolaou smear. Obstet Gynecol 1997;90:755-758
9. Elias A, Lintgorst G, Bekker B, Vooijs GP: The significance of endocervical cells in the diagnosis of cervical epithelial changes. Acta Cytol 1983;27:22-229
10. Mc Googan E, Colgan TJ, Ramzy I: Cell preparation methods and criteria for sample adequacy. Acta Cytol 1998;42:25-29
11. Mintzer M, Curtis P, Resnik JC, Morrel D: The effect of the quality of Papanicolaou smear on the detection of cytologic abnormalites. Cancer 1999;87:113-117
12. Gay JD, Donaldson LD, Goellner JR: False-negative results in cervical cytologic studies. Acta Cytol 1985;29:1043-1046
13. Sherman ME, Kelly D: High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression? Mod Pathol 1992;5:337-342
14. Buntinx F, Brouwers M: Relation between sampling device and detection of abnormality in cervical smears: A meta-analysis of randomised and quasi-randomised studies. BMJ 1996;313: 1285-1290
15. Agoff SN, Dean T, Nixon BK, Ingalls-Severn K, Rinker L, Grieco VS: The efficacy of reprocessing unsatisfactory cervicovaginal ThinPrep specimens with and without glacial acetic acid: Effect on Hybrid Capture II human papillomavirus testing and clinical follow-up. Am J Clin Pathol 2002;118:727-732
16. Miller AB: Quality assurance in screening strategies. Virus Res 2002;89:295-299
17. Greer BE: The gynaecologist's perspective of liability and quality issues with the Papanicoloau smear. Arch Pathol Lab Med 1997;121:246-249
18. Slater DN, Hewer EM, Melling SE, Rice S: External quality assessment in gynaecological cytology: The Trent region experience. Cytopathology 2002;13:206-219
19. Gifford C, Coleman DV: Quality assurance in cervical cancer screening: results of a proficiency testing scheme for cytology laboratories in the northwest Thames region. Cytopathology 1994;5:197-206
20. Branca M, Duca PG, Riti MG, Rossi E, Leoncini L, Turolla E, Morosi PL: Reliability and accuracy of reporting cervical intraepithelial neoplasia (CIN) in 15 laboratories thoughout Italy: Phase 1 national programme of external quality control in cervical screening: The National Working Group for External Quality Control in Cervical Screening. Cytopathology 1996;7: 159-172
21. Nanda K, McCrory DC, Myeres ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810-819
22. Joste NE, Crum CP, Cibas ES: Cytologic/histologic correlation for quality control in cervicaovaginal cytology: Experience with 1,582 paired cases. Am J Clin Pathol 1995;103:32-34
23. Arbyn M, Schenck U: Detection of false negative Pap smears by rapid reviewing: A metaanalysis. Acta Cytol 2000;44:949-957
24. Farrell DJ, Bilkhu S, Gibson LM, Cummings L, Wadehra V:. Rapid screening of cervical smears as a method of internal quality control: For how long should we rescreen? Acta Cytol 1997; 41:251-260.
25. Ortiz Vásquez G, Duarte Torres R, Ortega RH, Murguia Riechers L, Sosa Casarin C, Robles Sánchez S, Salazar Marinez E, Romero Guadarra M, Alonso de Ruiz P: Control de calidad interno en citologia cérvico-vaginal mediante revisión rápida: Evaluación de la capacidad del personal del laboratorio para utilizar el procdimiento/rapid rescreening as internal control in cervical citology. Rev Med Hosp Gen Mex 2001;64:6-10
26. Renshaw AA, Bellerose B, DiNisco SA, Minter LJ, Lee KR: False negative rate of cervical cytologic smear screening as determined by rapid rescreening. Acta Cytol 1999;43:344-350
27. Arbyn M, Schenck U, Ellison E, Hanselaar A: Metaanalysis of the accuracy of rapid prescreening relative to full screening of Pap smears. Cancer 2003;99:9-16
28. Alves VAF, Bibbo M, Schmitt FCL, Milanezi F, Longatto Filho A: Comparison of manual and automated methods of liquid-based cytology: A morphologic study. Acta Cytol 2004;48:187-193
29. Gardner NM: In-house quality assurance program in a state cytology laboratory. Acta Cytol 1989;33:487-488
30. Flisser A, Garcia-Malo F, Canepa MA, Doncel S, Tech C, Espinoza R, Moreno R, Avila I, Pérez-Palacios G, Tapia-Conyer R, de la Fuente JR: Implementation and evaluation of a national external quality control program for cervical cytology in Mexico. Salud Publica Mex 2002;44:431-436
31. Sasieni P: Cancer screening for medical oncologists: Importance of quality control and audit. Ann Oncol 2002;13:199-204
32. Hadwin RJ, Walker PG: Quality control assurance in national screening programmes for cervical cancer. Ann Acad Med Singapore 2003;32:632-637
33. Farnsworth A, Mitchell HS: Prevention of cervical cancer. Med J Aust 2003;178:653-654
34. Bleggi-Torres LF, Werner B, Totsugui J, Collaço LM, Araujo SR, Huculak M, Boza EJ, Fisher RM, De Laat L, Sobbania LC, Raggio A: Cervical cancer screening program of Parana: Cost-effective model in a developing country. Diagn Cytopathol 2003;29:49-54
35. Salvetto M, Sandiford P: Exernal quality assurance for cervical cytology in developing countries: Experience in Peru and Nicaragua. Acta Cytol 2004;48:23-31
36. Pohar-Marinsek Z, Pogacnick A: Cytopathology in Slovenia. Cytopathology 2004;15:53-57
37. Schneider V, Henry MR, Jimenez-Ayala M, Turnbull LS, Wroght TC: Cervical cancer screening: Screening errors and reporting. Acta Cytol 2001;45:493-498
38. Tabbara SO, Sidawy MK: Evaluation of the 10% rescreen of negative gynecologic smears as a quality assurance measure. Diagn Cytopathol 1996;14:84-86
39. Pereira SMM, Utagawa ML, Pittoli JE, Aguiar LS, Maeda MYS, Longatto Filho A, di Loreto C, Roteli-Martins C, Galvane JO, Wolf CM, Figueiredo SF, Syrjanen K: Cellularity evaluation in liquid-based cytology preparations. Rev Inst Adolfo Lutz 2003;62:35-39
40. Quitllet FA, Campmajö EG, Albert S, Romero E, Soler I, Yabar MDF, Morta MC, Figueras SS: ASCUS y control citológico. Rev Esp Patol 2003;36:65-70
41. Birdsong GG: Pap smear adequacy: Is our understanding satisfactory ... or limited? Diagn Cytopathol 2000;24:79-81